138 related articles for article (PubMed ID: 10680973)
1. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system.
Yokoyama M; Okano T; Sakurai Y; Fukushima S; Okamoto K; Kataoka K
J Drug Target; 1999; 7(3):171-86. PubMed ID: 10680973
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of adriamycin-incorporated polymeric micelles of poly(gamma-benzyl L-glutamate)/poly(ethylene oxide).
Jeong YI; Na HS; Cho KO; Lee HC; Nah JW; Cho CS
Int J Pharm; 2009 Jan; 365(1-2):150-6. PubMed ID: 18786625
[TBL] [Abstract][Full Text] [Related]
3. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor.
Yokoyama M; Fukushima S; Uehara R; Okamoto K; Kataoka K; Sakurai Y; Okano T
J Control Release; 1998 Jan; 50(1-3):79-92. PubMed ID: 9685875
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments.
Bae Y; Nishiyama N; Kataoka K
Bioconjug Chem; 2007; 18(4):1131-9. PubMed ID: 17488066
[TBL] [Abstract][Full Text] [Related]
5. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
6. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles.
Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ
Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183
[TBL] [Abstract][Full Text] [Related]
7. Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system.
Wang Y; Yang T; Wang X; Dai W; Wang J; Zhang X; Li Z; Zhang Q
J Control Release; 2011 Feb; 149(3):299-306. PubMed ID: 21044651
[TBL] [Abstract][Full Text] [Related]
8. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
Greish K; Sawa T; Fang J; Akaike T; Maeda H
J Control Release; 2004 Jun; 97(2):219-30. PubMed ID: 15196749
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.
Yokoyama M; Okano T; Sakurai Y; Ekimoto H; Shibazaki C; Kataoka K
Cancer Res; 1991 Jun; 51(12):3229-36. PubMed ID: 2039998
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles.
Kawano K; Watanabe M; Yamamoto T; Yokoyama M; Opanasopit P; Okano T; Maitani Y
J Control Release; 2006 May; 112(3):329-32. PubMed ID: 16678929
[TBL] [Abstract][Full Text] [Related]
13. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
Greish K; Nagamitsu A; Fang J; Maeda H
Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
[TBL] [Abstract][Full Text] [Related]
14. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.
Cabral H; Nishiyama N; Kataoka K
J Control Release; 2007 Aug; 121(3):146-55. PubMed ID: 17628162
[TBL] [Abstract][Full Text] [Related]
15. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K
Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583
[TBL] [Abstract][Full Text] [Related]
16. Biological evaluation of polymeric micelles with covalently bound doxorubicin.
Vetvicka D; Hruby M; Hovorka O; Etrych T; Vetrik M; Kovar L; Kovar M; Ulbrich K; Rihova B
Bioconjug Chem; 2009 Nov; 20(11):2090-7. PubMed ID: 19835372
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonically activated chemotherapeutic drug delivery in a rat model.
Nelson JL; Roeder BL; Carmen JC; Roloff F; Pitt WG
Cancer Res; 2002 Dec; 62(24):7280-3. PubMed ID: 12499270
[TBL] [Abstract][Full Text] [Related]
18. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer.
Yokoyama M; Miyauchi M; Yamada N; Okano T; Sakurai Y; Kataoka K; Inoue S
Cancer Res; 1990 Mar; 50(6):1693-700. PubMed ID: 2306723
[TBL] [Abstract][Full Text] [Related]
19. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice.
Hattori Y; Ubukata H; Kawano K; Maitani Y
Int J Pharm; 2011 Jan; 403(1-2):178-84. PubMed ID: 20934498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
